Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 5
2004 4
2005 5
2006 4
2007 11
2008 12
2009 11
2010 21
2011 21
2012 20
2013 14
2014 14
2015 12
2016 11
2017 12
2018 8
2019 9
2020 4
2021 6
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Results by year

Filters applied: . Clear all
Page 1
Non-synonymous, synonymous, and non-coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression.
Stachelek K, Harutyunyan N, Lee S, Beck A, Kim J, Xu L, Berry JL, Nagiel A, Reynolds CP, Murphree AL, Lee TC, Aparicio JG, Cobrinik D. Stachelek K, et al. Among authors: reynolds cp. Genes Chromosomes Cancer. 2023 May;62(5):275-289. doi: 10.1002/gcc.23120. Epub 2023 Jan 5. Genes Chromosomes Cancer. 2023. PMID: 36550020 Free PMC article.
Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance.
Çoku J, Booth DM, Skoda J, Pedrotty MC, Vogel J, Liu K, Vu A, Carpenter EL, Ye JC, Chen MA, Dunbar P, Scadden E, Yun TD, Nakamaru-Ogiso E, Area-Gomez E, Li Y, Goldsmith KC, Reynolds CP, Hajnoczky G, Hogarty MD. Çoku J, et al. Among authors: reynolds cp. EMBO J. 2022 Apr 19;41(8):e108272. doi: 10.15252/embj.2021108272. Epub 2022 Feb 25. EMBO J. 2022. PMID: 35211994 Free PMC article.
ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156.
Koneru B, Farooqi A, Nguyen TH, Chen WH, Hindle A, Eslinger C, Makena MR, Burrow TA, Wilson J, Smith A, Pilla Reddy V, Cadogan E, Durant ST, Reynolds CP. Koneru B, et al. Among authors: reynolds cp. Sci Transl Med. 2021 Aug 18;13(607):eabd5750. doi: 10.1126/scitranslmed.abd5750. Sci Transl Med. 2021. PMID: 34408079 Free PMC article.
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors.
Thomas JS, El-Khoueiry AB, Maurer BJ, Groshen S, Pinski JK, Cobos E, Gandara DR, Lenz HJ, Kang MH, Reynolds CP, Newman EM. Thomas JS, et al. Among authors: reynolds cp. Cancer Chemother Pharmacol. 2021 Apr;87(4):525-532. doi: 10.1007/s00280-020-04224-8. Epub 2021 Jan 10. Cancer Chemother Pharmacol. 2021. PMID: 33423090 Free PMC article. Clinical Trial.
Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor.
Chasse MH, Johnson BK, Boguslawski EA, Sorensen KM, Rosien JE, Kang MH, Reynolds CP, Heo L, Madaj ZB, Beddows I, Foxa GE, Kitchen-Goosen SM, Williams BO, Triche TJ Jr, Grohar PJ. Chasse MH, et al. Among authors: reynolds cp. EMBO Mol Med. 2021 Feb 5;13(2):e12640. doi: 10.15252/emmm.202012640. Epub 2020 Dec 17. EMBO Mol Med. 2021. PMID: 33332735 Free PMC article.
178 results